Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 30:14:6383-6395.
doi: 10.2147/JIR.S268262. eCollection 2021.

Indeterminate Colitis - Update on Treatment Options

Affiliations
Review

Indeterminate Colitis - Update on Treatment Options

Niranjani Venkateswaran et al. J Inflamm Res. .

Abstract

Indeterminate colitis (IC) is described in approximately 5-15% of patients with inflammatory bowel disease (IBD). It usually reflects a difficulty or lack of clarity in distinguishing between ulcerative colitis (UC) and Crohn's disease (CD) on biopsy or colectomy specimens. The diagnostic difficulty may explain the variability in the reported prevalence and incidence of IC. Clinically, most IC patients tend to evolve over time to a definite diagnosis of either UC or CD. IC has also been interchangeably described as inflammatory bowel disease unclassified (IBDU). This review offers an overview of the available limited literature on the conventional medical and surgical treatments for IC. In contrast to the numerous studies on the medical management of UC and CD, there are very few data from dedicated controlled trials on the treatment of IC. The natural evolution of IC more closely mimics UC. Regarding medical options for treatment, most patients diagnosed with IC are treated similarly to UC, and treatment choices are based on disease severity. Others are managed similarly to CD if there are features suggestive of CD, including fissures, skin tags, or rectal sparing. In medically refractory IC, surgical treatment options are limited and include total proctocolectomy (TPC) and ileal pouch-anal anastomosis (IPAA), with its associated risk factors and complications. Post-surgical complications and pouch failure rates were historically thought to be more common in IC patients, but recent meta-analyses reveal similar rates between UC and IC patients. Future therapies in IBD are focused on known mechanisms in the disease pathways of UC and CD. Owing to the lack of IC-specific studies, clinicians have traditionally and historically extrapolated the data to IC patients based on their symptomatology, clinical course, and endoscopic findings.

Keywords: Crohn’s disease; ileal pouch–anal anastomosis; indeterminate colitis; medical treatment; total proctocolectomy; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors report no relevant conflicts of interest related to this review.

Similar articles

Cited by

References

    1. Maher MM. Inflammatory bowel disease: review and future view. Front Biosci. 2012;4:1638–1647. doi:10.2741/e485 - DOI - PubMed
    1. Meucci G, Bortoli A, Riccioli FA, et al. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur J Gastroenterol Hepatol. 1999;11(8):909–913. doi:10.1097/00042737-199908000-00018 - DOI - PubMed
    1. Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept–what’s in a name? Inflamm Bowel Dis. 2008;14(6):850–857. doi:10.1002/ibd.20361 - DOI - PubMed
    1. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease–“colitis indeterminate”. J Clin Pathol. 1978;31(6):567–577. doi:10.1136/jcp.31.6.567 - DOI - PMC - PubMed
    1. Kent TH, Ammon RK, DenBesten L. Differentiation of ulcerative colitis and regional enteritis of colon. Arch Pathol. 1970;89(1):20–29. - PubMed